Zigakibart for renal insufficiency, chronic

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 5 Mar 2025: Trial registered, NCT06858319
  2. 28 Jul 2025: Trial started, NCT06858319

The trials

NCT06858319: Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

State
Under way
Phase
Phase 3
People
220 planned
Started
28 Jul 2025
Primary completion
25 Jun 2031
Arms
zigakibart
Results
None posted
  1. 5 Mar 2025: Trial registered
  2. 28 Jul 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.